Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
Author:
Publisher
Wiley
Subject
Pathology and Forensic Medicine
Reference66 articles.
1. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
2. Expression of epidermal growth factor receptor in breast carcinoma.
3. The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
4. Role of HER2 gene overexpression in breast carcinoma
Cited by 492 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. miRNAs as biomarkers of therapeutic response to HER2-targeted treatment in breast cancer: A systematic review;Biochemistry and Biophysics Reports;2024-03
2. Anoikis-related mRNA-lncRNA and DNA methylation profiles for overall survival prediction in breast cancer patients;Mathematical Biosciences and Engineering;2024
3. Clinico-Pathological and Prognostic Significance of a Combination of Tumor Biomarkers in Iranian Patients With Breast Cancer;Clinical Breast Cancer;2024-01
4. Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3–Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3–Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial;Journal of Clinical Oncology;2023-12-20
5. Receptor tyrosine kinases: biological functions and anticancer targeted therapy;MedComm;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3